TP53 and breast cancer: In addition, CK2 inhibition induces premature senescence through the ROS-p53-p21Cip1/WAF1 pathway in human cells such as lung fibroblast IMR-90, colon cancer HCT116, and breast cancer MCF-7cells [11–15].